Genomics

Dataset Information

0

Transcriptional profiling of whole blood leukocytes obtained from critically ill patients with sepsis treated with clarithromycin, or not, and healthy particpants


ABSTRACT: To evaluate whether clarithromycin improves 28-day mortality among patients with sepsis, respiratory and multiple-organ dysfunction syndrome. The INntravenous CLArithromycin in Sepsis and multiple organ dysfunction Syndrome trial was a phase 3, randomized, double blind, placebo-controlled clinical study, conducted in 11 intensive care units and 2 Internal Medicine wards in 2 countries. Patients with sepsis, respiratory failure and total sequential organ failure assessment score of ≥7 were enrolled between December 2017 and September 2019. Follow-up lasted 90 days. Patients were randomized to receive 1 gr of intravenous clarithromycin or placebo once daily for 4 consecutive days.

ORGANISM(S): Homo sapiens

PROVIDER: GSE196117 | GEO | 2022/06/30

REPOSITORIES: GEO

Similar Datasets

2022-12-18 | GSE221234 | GEO
2023-04-20 | GSE229298 | GEO
| E-GEOD-84501 | biostudies-arrayexpress
| E-GEOD-63311 | biostudies-arrayexpress
2018-09-07 | GSE119571 | GEO
2016-07-19 | GSE84501 | GEO
| E-GEOD-34790 | biostudies-arrayexpress
2014-11-14 | GSE63311 | GEO
2022-03-10 | MSV000089030 | MassIVE
2019-04-15 | MSV000083690 | MassIVE